研究单位：[1] Responsible Party:[2]University of Alabama-The Kirklin Clinic [3]Digestive Health Specialists[4]Tongji Hosp Tongji Med Col Huazhong Univ of Sci & Tech
研究目的：
The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.
